Dr. Hafrun Fridriksdottir

Equibles does not estimate personal net worth.

About Dr. Hafrun Fridriksdottir

The proxy statement of Teva Pharmaceutical Industries Ltd reports total compensation of $4,290,333 for Dr. Hafrun Fridriksdottir in fiscal 2020, including a base salary of $720,000. Disclosed compensation is on record for 4 fiscal years.

Affiliation history

Teva Pharmaceutical Industries Ltd (TEVA)
Proxy statement

Start not stated–2022-06-20

Company network

Teva Pharmaceutical Industries Ltd

TEVA

Drug Manufacturers - Specialty & Generic · Healthcare

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2020	Teva Pharmaceutical Industries Ltd (TEVA)	Executive Vice President, GlobalResearch and Development	$720,000	$562,500	$1,999,987	$0	$828,576	$179,270	$4,290,333
2019	Teva Pharmaceutical Industries Ltd (TEVA)	Executive Vice President, GlobalResearch and Development	$720,000	$837,500	$1,899,988	$0	$734,832	$185,405	$4,377,725
2018	Teva Pharmaceutical Industries Ltd (TEVA)	Executive Vice President, GlobalResearch and Development	$720,000	$650,000	$2,321,392	$900,003	$1,296,144	$87,492	$5,975,031
2017	Teva Pharmaceutical Industries Ltd (TEVA)	Executive Vice President, GlobalResearch and Development	$696,346	$900,000	$999,957	$500,047	$535,000	$77,492	$3,708,842

Recent activity

No call appearances or filed executive changes recorded yet.